Valproate-induced hepatoxicity: protective effect of L-carnitine supplementation.
Sugimoto
T
T
Department of Pediatrics, Kansai Medical University, Otokoyama Hospital, Kyoto.
Nishida
N
N
Murakami
K
K
Woo
M
M
Sakane
Y
Y
Yasuhara
A
A
Shuto
H
H
Hatanaka
T
T
Kobayashi
Y
Y
D000927:Anticonvulsants / Q000008:administration & dosage; D002331:Carnitine / Q000008:administration & dosage*; D056486:Chemical and Drug Induced Liver Injury / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008111:Liver Function Tests; D008297:Male; D011502:Protein-Energy Malnutrition / Q000150:complications; D012307:Risk Factors; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects*
D000927:Anticonvulsants; D014635:Valproic Acid; D002331:Carnitine